Katarzyna T. U.
- Country
- Poland
- Department
- N/A
Research Overview
- A Phase 3b Long-term Efficacy and Safety Extension Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria
- Phase 2b Randomized Double‑Blind Placebo‑Controlled Dose‑Ranging Study of Oral PF‑08049820 in Adults with Moderate‑to‑Severe Atopic Dermatitis
- Phase 1 Single-Ascending Dose Study Assessing Safety, Tolerability, and Pharmacokinetics of PF-07832837 in Healthy Adults and Adults with Atopic Dermatitis
Data & Insights
Has run more than one trial at 313 of 534 partner sites.
Specializations
Atopic dermatitis and chronic eczematous disease
Clinical research activity includes moderate-to-severe atopic dermatitis, chronic hand eczema, and related eczematous conditions, with attention to persistent inflammation, itch, and skin-barrier dysfunction in adult and pediatric populations.
- Atopic dermatitis
- Chronic hand eczema
- Eczema Area and Severity Index endpoints
Therapeutic interest extends to topical and systemic approaches for controlling disease activity and improving cutaneous symptoms in inflammatory eczema.
Psoriasis and immune-mediated plaque disease
The investigator is involved in studies of moderate-to-severe plaque psoriasis and chronic plaque psoriasis, including pediatric disease, with focus on plaque clearance and sustained control of inflammatory skin lesions.
- Plaque psoriasis
- Pediatric psoriasis
- Psoriasis Area and Severity Index response
This area reflects interest in advanced immunomodulatory therapies for long-term management of psoriatic skin involvement.
Hidradenitis suppurativa and follicular inflammatory disorders
Research involvement covers hidradenitis suppurativa and overlapping follicular inflammatory disease, with clinical emphasis on lesion reduction, symptom burden, and durable disease suppression.
- Hidradenitis suppurativa
- Prurigo nodularis
- Inflammatory skin lesions
These activities align with therapeutic development in difficult-to-treat chronic dermatoses marked by pain, nodules, and recurrent flares.
Pruritus, urticaria, and itch-driven skin disease
The clinical portfolio includes disorders centered on pruritus and wheal-and-flare activity, particularly chronic spontaneous urticaria, chronic urticaria, and itch associated with notalgia paresthetica.
- Chronic spontaneous urticaria
- Pruritus in notalgia paresthetica
- Urticaria activity
Therapeutic focus includes symptom relief for itch-predominant conditions and control of recurrent inflammatory skin activation.
Alopecia areata, vitiligo, and other immune dermatologic disorders
Additional involvement includes alopecia areata, vitiligo, acne vulgaris, and primary discoid lupus erythematosus, reflecting interest in immune-mediated hair, pigment, and inflammatory skin disorders.
- Alopecia areata
- Vitiligo
- Primary discoid lupus erythematosus
These research areas include therapeutic strategies aimed at restoring skin and hair integrity while addressing autoimmune and inflammatory pathways.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.